Abstract:The presence of atherosclerotic plaque vessels is a critical factor in plaque destabilization. This may be attributable to the leaky phenotype of these microvessels, although direct proof for this notion is lacking. In this study, we investigated molecular and cellular patterns of stable and hemorrhaged human plaque to identify novel drivers of intraplaque vessel dysfunction. From transcriptome data of a human atherosclerotic lesion cohort, we reconstructed a co-expression network, identifying a gene module strongly and selectively correlated with both plaque microvascular density and inflammation. Spectrin Beta Non-Erythrocytic 1 ( sptbn1 ) was identified as one of the central hubs of this module (along with zeb1 and dock1 ) and was selected for further study based on its predominant endothelial expression. Silencing of sptbn1 enhanced leukocyte transmigration and vascular permeability in vitro, characterized by an increased number of focal adhesions and reduced junctional VE-cadherin. In vivo, sptbn1 knockdown in zebrafish impaired the development of the caudal vein plexus. Mechanistically, increased substrate stiffness was associated with sptbn1 downregulation in endothelial cells in vitro and in human vessels. Plaque SPTBN1 mRNA and protein expression were found to correlate with an enhanced presence of intraplaque hemorrhage and future cardiovascular disease (CVD) events during follow-up. In conclusion, we identify SPTBN1 as a central hub gene in a gene program correlating with plaque vascularisation. SPTBN1 was regulated by substrate stiffness in vitro while silencing blocked vascular development in vivo, and compromised barrier function in vitro. Together, SPTBN1 is identified as a new potential regulator of the leaky phenotype of atherosclerotic plaque microvessels.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the molecular mechanism of microvascular leakage in atherosclerotic plaques. Specifically, by analyzing the transcriptome data of human atherosclerotic lesion samples, the researchers constructed a co - expression network, aiming to identify gene modules that are strongly associated with plaque microvascular density and inflammation. During this process, they paid special attention to key molecules that may regulate the plaque microvascular leakage phenotype. The study found that Spectrin Beta Non - Erythrocytic 1 (SPTBN1) is a central hub in this gene module and is significantly expressed in endothelial cells. Further research indicates that the silencing of SPTBN1 enhances leukocyte migration and vascular permeability, suggesting that SPTBN1 may be a new potential regulator of the microvascular leakage phenotype in atherosclerotic plaques. ### Research Background Atherosclerosis is a chronic inflammatory disease, characterized by plaques formed by lipid deposition and fibrous tissue hyperplasia in the vessel wall. The neovascularization in these plaques is related to plaque instability and may lead to plaque rupture and the occurrence of cardiovascular events. However, these new blood vessels often have leakage properties, increasing the vulnerability of the plaques. Although some growth factors such as VEGF are known to be associated with vascular leakage, the specific molecular mechanisms are not fully understood, especially in human diseases. ### Research Objectives The main objective of this study was to analyze the transcriptome data of human atherosclerotic plaques to identify key gene modules associated with plaque microvascular density and inflammation, thereby finding new potential regulatory factors, especially those molecules that may regulate the microvascular leakage phenotype. ### Main Findings 1. **Identification of Gene Modules**: Through weighted gene co - expression network analysis (WGCNA), the researchers identified a gene module that is highly correlated with plaque microvascular density and inflammation. 2. **The Central Role of SPTBN1**: SPTBN1 was determined to be a central hub in this gene module and is significantly expressed in endothelial cells. 3. **Functional Verification**: In vitro experiments showed that the silencing of SPTBN1 enhanced leukocyte migration and vascular permeability, reduced VE - cadherin expression between endothelial cells, and increased the number of focal adhesions. 4. **In Vivo Verification**: In the zebrafish model, the knockdown of SPTBN1 led to impaired development of the caudal vein plexus, further supporting the important role of SPTBN1 in vascular development and barrier function. 5. **Regulatory Mechanism of SPTBN1**: The study found that the expression of SPTBN1 is regulated by matrix stiffness. An increase in matrix stiffness leads to a decrease in SPTBN1 expression, which may explain why SPTBN1 expression is reduced in advanced atherosclerotic plaques. ### Conclusions SPTBN1 was identified as a potential regulator associated with the microvascular leakage phenotype in atherosclerotic plaques. The expression of SPTBN1 is regulated by matrix stiffness, and its silencing can lead to impaired endothelial cell barrier function, enhanced vascular permeability, and leukocyte migration. These findings provide a new perspective for understanding the molecular mechanism of microvascular leakage in atherosclerotic plaques and may provide targets for the development of new treatment strategies.

Human atherosclerotic plaque transcriptomics reveals endothelial beta-2 spectrin as a potential regulator a leaky plaque microvasculature phenotype

Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics

Plaque Evaluation by Ultrasound and Transcriptomics Reveals BCLAF1 as a Regulator of Smooth Muscle Cell Lipid Transdifferentiation in Atherosclerosis

Abstract 143: Multi-omics Integration From A Large Human Biobank Identifies Key Molecular Mechanisms And Signatures Of Atherosclerotic Plaque Instability

Quantitative proteomic landscape of unstable atherosclerosis identifies molecular signatures and therapeutic targets for plaque stabilization

Atherosclerotic Plaque Epigenetic Age Acceleration Predicts a Poor Prognosis and Is Associated With Endothelial-to-Mesenchymal Transition in Humans

Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease

Differentially expressed genes and canonical pathway expression in human atherosclerotic plaques – Tampere Vascular Study

N-Terminal proteomics reveals distinct protein degradation patterns in different types of human atherosclerotic plaques

Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification

Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability

Intersecting single-cell transcriptomics and genome-wide association studies identifies crucial cell populations and candidate genes for atherosclerosis

Human atherosclerotic plaque macrophages associate with clinical presentation and follow diverse lineage differentiation routes

Proteomic Atlas of Atherosclerosis: The Contribution of Proteoglycans to Sex Differences, Plaque Phenotypes, and Outcomes

Wall shear stress-related plaque growth of lipid-rich plaques in human coronary arteries: an near-infrared spectroscopy and optical coherence tomography study

Spatial Transcriptomic Approach to Understanding Coronary Atherosclerotic Plaque Stability

ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1

Clonal Proliferation Within Smooth Muscle Cells in Unstable Human Atherosclerotic Lesions

Abstract 505: Cross Talk Between T Cells And Vascular Smooth Muscle Cells May Contribute To Phenotypic Changes In Human Coronary Plaque

Abstract 109: A Spatial Transcriptomic Approach to Understanding Coronary Atherosclerotic Plaque Stability

Proteomics of Plaques and Novel Sources of Potential Biomarkers for Atherosclerosis